肺移植受者COVID-19的CT影像表现
本回顾性多中心研究纳入51例因COVID-19住院的肺移植受者(LTR)与75例非移植对照(NTC),比较胸部CT表现。LTR以实变为主型最常见,且RSNA分类为不确定型的比例更高,CT评分及QCT高衰减区百分比提示病变更广泛、更严重。
要点
- 肺移植受者COVID-19的CT表现以实变为主型最常见,而非移植对照以磨玻璃影为主型更常见。
- LTR按RSNA分类为不确定型的比例显著高于对照,影像不典型时不能排除COVID-19,需依赖病原学检测。
- LTR的肺部病变范围及严重程度(CT评分、QCT %HAA)显著高于非移植对照。
关键影像表现/征象
- LTR中最常见的肺衰减模式为实变为主型(0.39 vs. 对照0.22,p=0.144),其次为磨玻璃影与实变混合型(0.37 vs. 0.20,校正p=0.102)。
- 非移植对照中最常见的模式为磨玻璃影为主型(0.58 vs. LTR 0.24,p=0.001)。
- LTR按RSNA分类为不确定型的比例显著高于对照(0.31 vs. 0.11,p=0.014)。
- LTR的CT评分及QCT %HAA均显著高于对照(0.372 ± 0.08 vs. 0.148 ± 0.06,p < 0.001),提示病变更严重。
诊断标准与关键数值
- RSNA分类不确定型比例:LTR 0.31 vs. 非移植对照0.11,p=0.014。
- 实变为主型比例:LTR 0.39 vs. 对照0.22,p=0.144;磨玻璃影与实变混合型:LTR 0.37 vs. 对照0.20,校正p=0.102。
- 磨玻璃影为主型比例:非移植对照0.58 vs. LTR 0.24,p=0.001。
- 定量CT高衰减区百分比(%HAA,阈值-250至-700 HU):LTR 0.372 ± 0.08 vs. 对照0.148 ± 0.06,p < 0.001。
临床应用与阅片要点
- 肺移植受者出现下呼吸道感染症状时,即使CT表现不典型或为RSNA不确定型,也应进行COVID-19病原学检测以明确诊断。
- 阅片时注意LTR的COVID-19更常表现为实变为主型而非磨玻璃影为主型,与普通人群表现不同。
- 可利用CT评分及QCT高衰减区百分比评估LTR肺部病变的严重程度和范围。
局限性
- 回顾性研究设计。
- 样本量有限(LTR 51例,对照75例),来自两家中心。
- 部分比较(如实变为主型p=0.144、混合型校正p=0.102)未达到统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Our goal was to compare the chest computed tomography (CT) imaging findings of COVID-19 in lung transplant recipients (LTR) and a group of non-transplanted controls (NTC).
METHODS: This retrospective study included 51 consecutive LTR hospitalized with COVID-19 from two centers. A total of 75 NTC were included for comparison. Images were classified regarding the standardized RSNA category, main pattern of lung attenuation, and longitudinal and axial distribution. Quantitative CT (QCT) analysis was performed to evaluate percentage of high attenuation areas (%HAA, threshold -250 to -700 HU). CT scoring was used to measure severity of parenchymal abnormalities.
RESULTS: The imaging findings of COVID-19 in LTR were significantly different from controls regarding the RSNA classification and pattern of lung attenuation. LTR had a significantly higher proportion of patients with an indeterminate pattern on CT (0.31 vs. 0.11, p = 0.014). The most frequent pattern of attenuation in LTR was predominantly consolidation (0.39 vs. 0.22, p = 0.144) followed by a mixed pattern of ground-glass opacities (GGO) and consolidation (0.37 vs. 0.20, adjusted p = 0.102). On the other hand, the most common pattern in NTC was GGO predominant (0.58 vs. 0.24 of LTR, p = 0.001). LTR had significantly more severe parenchymal disease measured by CT score and %HAA by QCT (0.372 ± 0.08 vs. 0.148 ± 0.06, p < 0.001).
CONCLUSION: The most frequent finding of COVID-19 in LTR is a predominant pattern of consolidation. Compared to NTC, LTR more frequently demonstrated an indeterminate pattern according to the RSNA classification and more extensive lung abnormalities on QCT and semi-quantitative scoring.
KEY POINTS: • The most common CT finding of COVID-19 in LTR is a predominant pattern of consolidation followed by a mixed pattern of GGO and consolidation, while controls more often have a predominant pattern of GGO. • LTR more often presents with an indeterminate pattern of COVID-19 by RSNA classification than controls; therefore, molecular testing for COVID-19 is essential for LTR presenting with lower airway infection independently of imaging findings. • LTR had more extensive disease by semi-quantitative CT score and increased percentage areas of high attenuation on QCT.
引用
- Hochhegger, Pelaez, Machuca, et al. CT imaging findings in lung transplant recipients with COVID-19. Eur Radiol. 2022. PMID: 36152040. doi:10.1007/s00330-022-09148-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。